Start for free
Start for free
Dafna Capital Management logo

Dafna Capital Management

North America, California, United States, Los Angeles

Description

Dafna Capital Management is an investment advisor that specializes in managing client portfolios of biotechnology companies.

Investor Profile

Dafna Capital Management has made 16 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (88%)
  • Series Unknown (13%)

Country Focus

  • United States (81%)
  • Switzerland (6%)
  • Israel (6%)
  • Sweden (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Medical
  • Health Diagnostics
  • Genetics
  • Life Science
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dafna Capital Management frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Blue Owl
Blue Owl
North America, New York, United States, New York
Co-Investments: 2
Iroquois Capital
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 3
Samsara BioCapital
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 2
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
Bain Capital Life Sciences
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 3
Boxer Capital
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

What are some of recent deals done by Dafna Capital Management?

Palvella Therapeutics

Wayne, Pennsylvania, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

BiotechnologyHealth CareLife ScienceTherapeutics
Post Ipo EquityDec 13, 2024
Century Therapeutics

Philadelphia, Pennsylvania, United States

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

BiotechnologyHealth CareHealth Diagnostics
Post Ipo EquityApr 11, 2024
Amount Raised: $60,000,000
Aprea

Stockholm, Stockholms Lan, Sweden

Aprea is a biopharmaceutical company that develops novel cancer therapeutics.

BiotechnologyHealth CareMedicalPersonal HealthPharmaceutical
Post Ipo EquityMar 11, 2024
Amount Raised: $16,000,000
Syros Pharmaceuticals

Watertown, Massachusetts, United States

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

BiotechnologyGeneticsLife SciencePharmaceutical
Post Ipo EquityDec 19, 2023
Amount Raised: $45,000,000
Compass Therapeutics, Inc.

Boston, Massachusetts, United States

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

BiopharmaBiotechnologyTherapeutics
Post Ipo EquityNov 2, 2022
Amount Raised: $80,000,000
KAHR medical

Jerusalem, Yerushalayim, Israel

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

BiotechnologyMedicalPharmaceutical
Series UnknownJun 16, 2021
Amount Raised: $46,500,000
Gemini Therapeutics

Cambridge, Massachusetts, United States

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

BiopharmaBiotechnologyHealth Diagnostics
Post Ipo EquityFeb 8, 2021
Amount Raised: $95,000,000
ObsEva

Plan-les-ouates, Geneve, Switzerland

ObsEva is a speciality biopharmaceutical company developing drugs for women’s reproductive medicine.

BiotechnologyPharmaceuticalTherapeuticsWomen's
Post Ipo EquityOct 10, 2017
Amount Raised: $60,000,000
Ardelyx

Fremont, California, United States

Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.

BiotechnologyHealth CareMedical
Post Ipo EquityJul 18, 2016
Amount Raised: $110,000,000
Corbus Pharmaceuticals

Norwood, Massachusetts, United States

Corbus Pharmaceuticals is a clinical-stage pharmaceutical company focused on treating inflammatory and fibrotic diseases.

BiotechnologyClinical TrialsPharmaceutical
Post Ipo EquityJun 10, 2016
Amount Raised: $14,800,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator